Drug Profile
Bardoxolone
Alternative Names: CDDO; RTA-401Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Cornell University; Dartmouth College
- Developer Biogen
- Class Antineoplastics
- Mechanism of Action Apoptosis stimulants; Cyclo-oxygenase 2 inhibitors; NF-kappa B inhibitors; Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Inflammation; Leukaemia; Solid tumours